Received Apr 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
sick; hives; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: sick) and hives (Verbatim: hives). The outcome of the sickness and hives were unknown. It was unknown if the reporter considered the sickness and hives to be related to Shingles vaccine. It was unknown if the company considered the sickness and hives to be related to Shingles vaccine. Additional Information: GSK receipt date: 16-APR-2026 This case was reported by a patient via interactive digital media. The patient reported that she had shingles vaccine and the second dose made her very sick and hives. The batch number was not provided, and we are unable to contact the reporter.